Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,128 | 235 | 98.3% |
| Education | $69.47 | 4 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $672.74 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $610.32 | 27 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $494.07 | 30 | $0 (2024) |
| Lilly USA, LLC | $395.89 | 27 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $279.44 | 15 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $257.24 | 16 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $240.31 | 12 | $0 (2020) |
| ABBVIE INC. | $220.01 | 11 | $0 (2024) |
| PFIZER INC. | $189.28 | 11 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $158.52 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $840.91 | 47 | Novo Nordisk Inc ($354.64) |
| 2023 | $636.11 | 35 | Novo Nordisk Inc ($283.70) |
| 2022 | $435.81 | 27 | SANOFI-AVENTIS U.S. LLC ($101.90) |
| 2021 | $610.40 | 41 | Takeda Pharmaceuticals U.S.A., Inc. ($137.65) |
| 2020 | $953.00 | 53 | AstraZeneca Pharmaceuticals LP ($252.86) |
| 2019 | $323.74 | 15 | AstraZeneca Pharmaceuticals LP ($135.48) |
| 2018 | $307.95 | 15 | AstraZeneca Pharmaceuticals LP ($206.93) |
| 2017 | $89.39 | 6 | Supernus Pharmaceuticals, Inc. ($41.10) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.40 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 09/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Obesity | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: DIABETES | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Obesity | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: DIABETES | ||||||
| 06/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Obesity | ||||||
| 06/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 733 | 1,096 | $104,028 | $64,355 |
| 2022 | 12 | 927 | 1,292 | $123,707 | $68,009 |
| 2021 | 13 | 991 | 1,474 | $136,724 | $86,700 |
| 2020 | 12 | 910 | 1,405 | $118,735 | $68,009 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 218 | 218 | $28,340 | $26,031 | 91.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 347 | $43,375 | $25,241 | 58.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 170 | $20,400 | $8,259 | 40.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 110 | 265 | $6,625 | $2,454 | 37.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $2,123 | $1,686 | 79.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 14 | 16 | $1,440 | $486.48 | 33.8% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 14 | 34 | $850.00 | $120.37 | 14.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 25 | 35 | $875.00 | $77.00 | 8.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 232 | 232 | $30,160 | $26,538 | 88.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 219 | 324 | $40,500 | $21,252 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 208 | 278 | $33,360 | $12,094 | 36.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 130 | 267 | $6,675 | $2,498 | 37.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 14 | 14 | $2,702 | $2,054 | 76.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $2,080 | $1,905 | 91.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $1,625 | $788.05 | 48.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 11 | 12 | $1,080 | $445.15 | 41.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 32 | 34 | $2,550 | $206.61 | 8.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 14 | $700.00 | $118.24 | 16.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 32 | 43 | $1,075 | $95.53 | 8.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 11 | 48 | $1,200 | $14.36 | 1.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 249 | 249 | $32,370 | $31,055 | 95.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 267 | 413 | $44,165 | $21,472 | 48.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 184 | 279 | $34,875 | $21,090 | 60.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 20 | 20 | $3,200 | $3,181 | 99.4% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 15 | 18 | $3,960 | $3,168 | 80.0% |
About Dr. Mark Reed, M.D
Dr. Mark Reed, M.D is a Nurse Practitioner healthcare provider based in Pikeville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992768261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Reed, M.D has received a total of $4,197 in payments from pharmaceutical and medical device companies, with $840.91 received in 2024. These payments were reported across 239 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,128).
As a Medicare-enrolled provider, Reed has provided services to 3,561 Medicare beneficiaries, totaling 5,267 services with total Medicare billing of $287,073. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family, Family Medicine
- Location Pikeville, KY
- Active Since 04/08/2006
- Last Updated 09/30/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992768261
Products in Payments
- JARDIANCE (Drug) $461.79
- FARXIGA (Drug) $422.10
- Ozempic (Drug) $278.34
- TRULICITY (Drug) $262.85
- Wegovy (Drug) $258.49
- TRINTELLIX (Drug) $241.11
- XARELTO (Drug) $199.36
- SOLIQUA 100/33 (Biological) $192.80
- VOQUEZNA (Drug) $158.52
- Rybelsus (Drug) $135.91
- SYMBICORT (Drug) $115.57
- TROKENDI XR (Drug) $109.70
- UBRELVY (Drug) $103.43
- TOUJEO (Biological) $86.64
- QULIPTA (Drug) $80.71
- NURTEC ODT (Drug) $80.34
- JANUVIA (Drug) $78.46
- ELIQUIS (Drug) $78.39
- QUVIVIQ (Drug) $63.99
- SPIRIVA RESPIMAT (Drug) $52.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Pikeville
Staci Taylor, Aprn, APRN
Nurse Practitioner — Payments: $9,527
Ginger Webb, Aprn, APRN
Nurse Practitioner — Payments: $8,155
Elizabeth Branham, Aprn, APRN
Nurse Practitioner — Payments: $7,078
Kendra Drake, Aprn, APRN
Nurse Practitioner — Payments: $6,951
Angela Webb
Nurse Practitioner — Payments: $4,058
Betty Reynolds, Aprn, APRN
Nurse Practitioner — Payments: $3,559